Theyre pairing the medication with intensive lifestyle support, building clinical criteria that reflect actual metabolic risk, and measuring outcomes that go beyond pharmacy spend
Instead, it often reflects overlapping biological and neurological factors, including: Hormonal changes associated with aging, perimenopause, menopause, or postpartum periods Shifts in hormone levels , even when standard lab values appear normal. Genetic predispositions affecting neurotransmitter or receptor activity Metabolic conditions such as diabetes or insulin resistance Declines in overall metabolic health Chronic stress, fatigue, or nervous system dysregulation Traditional approaches often emphasize estrogen, testosterone, or other hormonal therapies
Lenzi, F
Sulforaphane Alleviates Muscular Dystrophy in Mdx Mice by Activation of Nrf2
These views are not necessarily endorsed or verified by the National Academy of Medicine or the National Academies of Sciences, Engineering, and Medicine and should not be construed as reflecting any group consensus